Biotech News

Assertio to Participate in the HC Wainwright and Lake Street Conferences in September 2025

Assertio (ASRT)Assertio2025-09-03 12:15 ESTFinancing

Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) announced that members of its management team will host investor meetings at two investor conferences in New York City during September 2025.

Company management will host investor meetings at the HC Wainwright Conference on Wednesday, September 10, 2025, taking place at the Lotte New York Palace Hotel. Investors can register and request meetings via their HC Wainwright representative.

The Company will also participate in investor meetings at the Lake Street Capital Markets BIG9 Conference, taking place September 11, 2025 at the Yale Club New York City. Investors can register and request meetings through their Lake Street representative.

About Assertio

Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management. To learn more about Assertio, visit www.assertiotx.com .

Investor Contact

Matt Kreps, Managing Director Darrow Associates M: 214-597-8200 [email protected]

Assertio

Assertio is a specialty pharmaceutical company with a portfolio of neurology, pain, and related products. The story is largely about managing a concentrated commercial base while expanding selectively.

Recent company news

ASRTAssertio2025-10-28 13:15 EST

Assertio Announces Leadership Transition

ASRTAssertio2025-09-15 13:00 EST

Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN® (clobazam) Oral Film, CIV

ASRTAssertio2025-09-10 11:30 EST

Assertio to Present New Data from Real-World Evidence Study of SYMPAZAN® at upcoming 150th Annual Meeting of the American Neurological Association

ASRTAssertio2025-09-03 12:15 EST